1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
- 2017
-
Mark
Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden
(
- Contribution to journal › Letter
-
Mark
Early death rates remain high in high-risk APL : Update from the Swedish Acute Leukemia Registry 1997-2013
(
- Contribution to journal › Letter
- 2016
-
Mark
An open-label phase I dose-finding study of APR-246 in hematological malignancies
(
- Contribution to journal › Article
- 2004
-
Mark
Low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma
(
- Contribution to journal › Article
-
Mark
Early response predicts thalidomide efficiency in patients with advanced multiple myeloma
(
- Contribution to journal › Article
- 2003
-
Mark
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
(
- Contribution to journal › Article